Forget-Me-Not: The Primary Hemostasis Defect in Extracorporeal Membrane Oxygenation May Require Unique Treatment
- PMID: 35439191
- DOI: 10.1097/MAT.0000000000001745
Forget-Me-Not: The Primary Hemostasis Defect in Extracorporeal Membrane Oxygenation May Require Unique Treatment
Comment in
-
More to Learn About Acquired Von Willebrand Syndrome.ASAIO J. 2023 Jan 1;69(1):e53. doi: 10.1097/MAT.0000000000001744. Epub 2022 May 19. ASAIO J. 2023. PMID: 35593748 No abstract available.
Comment on
-
2021 ELSO Adult and Pediatric Anticoagulation Guidelines.ASAIO J. 2022 Mar 1;68(3):303-310. doi: 10.1097/MAT.0000000000001652. ASAIO J. 2022. PMID: 35080509
References
-
- McMichael ABV, Ryerson LM, Ratano D, Fan E, Faraoni D, Annich GM: 2021 ELSO Adult and pediatric anticoagulation guidelines . ASAIO J. 68: 303–310, 2022.
-
- Kalbhenn J, Schlagenhauf A, Rosenfelder S, Schmutz A, Zieger B: Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: rapid onset and fast recovery. J Heart Lung Transplant. 37: 985–991, 2018.
-
- Chen Z, Koenig SC, Slaughter MS, Griffith BP, Wu ZJ: Quantitative characterization of shear-induced platelet receptor shedding: Glycoprotein Ibα, Glycoprotein VI, and Glycoprotein IIb/IIIa. ASAIO J. 64: 773–778, 2018.
-
- Mazzeffi M, Bathula A, Tabatabai A, et al.: Von Willebrand factor concentrate administration for acquired Von Willebrand syndrome- related bleeding during adult extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth. 35: 882–887, 2021.
-
- Mazzeffi M, Henderson R, Krause E, et al.: In Vitro comparison of recombinant and plasma-derived von Willebrand factor concentrate for treatment of acquired von Willebrand syndrome in adult extracorporeal membrane oxygenation patients. Anesth Analg. 134: 312–321, 2022.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources